Dickkopf-2 regulates the stem cell marker LGR5 in colorectal cancer via HNF4 alpha 1
- Authors
- Shin, Jae Hun; Jeong, Jaekwang; Choi, Jungmin; Lim, Jaechul; Dinesh, Ravi K.; Braverman, Jonathan; Hong, Jun Young; Maher, Stephen E.; Vesely, Maria C. Amezcua; Kim, WonJu; Koo, Ja-Hyun; Tang, Wenwen; Wu, Dianqing; Blackburn, Holly N.; Xicola, Rosa M.; Llor, Xavier; Yilmaz, Omer; Choi, Je-Min; Bothwell, Alfred L. M.
- Issue Date
- 21-5월-2021
- Publisher
- CELL PRESS
- Keywords
- Cancer; Cell Biology; Stem Cells Research
- Citation
- ISCIENCE, v.24, no.5
- Indexed
- SCIE
SCOPUS
- Journal Title
- ISCIENCE
- Volume
- 24
- Number
- 5
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/128013
- DOI
- 10.1016/j.isci.2021.102411
- ISSN
- 2589-0042
- Abstract
- Enhanced stemness in colorectal cancer has been reported and it contributes to aggressive progression, but the underlying mechanisms remain unclear. Here we report a Wnt ligand, Dickkopf-2 (DKK2) is essential for developing colorectal cancer stemness. Genetic depletion of DKK2 in intestinal epithelial or stem cells reduced tumorigenesis and expression of the stem cell marker genes including LGR5 in a model of colitis-associated cancer. Sequential mutations in APC, KRAS, TP53, and SMAD4 genes in colonic organoids revealed a significant increase of DKK2 expression by APC knockout and further increased by additional KRAS and TP53 mutations. Moreover, DKK2 activates proto-oncogene tyrosine-protein kinse Src followed by increased LGR5 expressing cells in colorectal cancer through degradation of HNF4 alpha 1 protein. These findings suggest that DKK2 is required for colonic epithelial cells to enhance LGR5 expression during the progression of colorectal cancer.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.